echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Opening up "green channel" for Internet in many provinces to guarantee the supply demand of drugs for epidemic prevention and control

    Opening up "green channel" for Internet in many provinces to guarantee the supply demand of drugs for epidemic prevention and control

    • Last Update: 2020-02-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network industry trends] winter is over, spring is on schedule As the epidemic enters a critical period, the whole country, working together, will surely win this anti epidemic war In the face of the epidemic, the supply of drugs for prevention and control has also been highly valued According to the analysis, the author learned that at present, Shandong, Fujian, Heilongjiang and other provinces have opened up a "green channel" for related drug networks to ensure the supply of drugs for epidemic prevention and control Shandong In order to do a good job in the procurement monitoring and supply guarantee of drugs needed for epidemic prevention and control, Shandong Province has established a drug procurement guarantee group to open up a "green channel" for emergency Internet access, and started the prevention and control of drug emergency Internet access in the national diagnosis and treatment plan in advance The implementation of new drugs without price can be directly online traded according to the average price of drugs of the same variety within the platform with the consent of the enterprise 。 According to reports, since the start of the project, a total of 13 products of 8 enterprises including Shandong Yikang have been directly connected to the Internet for trading according to the "green channel" In addition, Shandong Province also quickly launched the "green channel" for emergency hanging of medical consumables such as masks, protective clothing, disinfectant, etc to guide the online operation of related enterprises by telephone At present, five production enterprises have registered on the platform to ensure the clinical supply of prevention and control of medical equipment At the same time, it also sorts out the contact information of the drug production enterprises for prevention and control in the platform in time, and submits it to the business supervision department, so as to facilitate the timely dispatch and use in case of drug shortage Easy access to green novel coronavirus infection was released in Heilongjiang province by the end of January, in Heilongjiang province Novel coronavirus novel coronavirus infection is a new green way for medical institutions and pharmaceutical production (operation) enterprises to prevent and control new coronavirus infection According to the notice, easy access to the relevant drugs for prevention and control of acute coronavirus infection in medical institutions is urgently needed If the novel coronavirus infection related pneumonia drugs were not detected in Heilongjiang Province, the medical institutions could purchase the direct bargaining line with the production enterprises Easy access to the novel coronavirus infection related pneumonia drugs is needed for drug manufacturers to open up green channels and hang along with them to ensure clinical use On January 31, Fujian Provincial Medical Insurance Bureau and Provincial Department of Finance jointly issued a notice to the medical insurance, financial department and relevant distribution enterprises in each city divided into districts, Pingtan Comprehensive Experimental Zone, requesting that the list of drugs purchased by medical institutions proposed by the health department should be reasonably configured and prepared to ensure the clinical demand According to the notice, the relevant distribution enterprises should further strengthen the allocation of drugs, organize the source of goods through multiple channels, implement the order response strictly according to the regulations, and give priority to the supply of designated medical institutions for treatment For the treatment and control drugs purchased in the list from January 24, 2020 to the end of the epidemic, if the stock cannot be digested through daily sales after the end of the epidemic, the relevant distribution enterprises can apply to the local medical insurance department, and after examination, the same level finance will arrange a special subsidy (not from the provincial special subsidy for epidemic prevention and control) It is worth noting that the notice also emphasizes that any unit or individual who finds any illegal and disciplinary behavior such as fraud, favoritism and malpractice in the process of drug allocation for epidemic prevention and control of drug distribution enterprises can report to the medical insurance department or other departments at the same level in a timely manner, and once verified, the relevant departments shall deal with it strictly and seriously according to the provisions.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.